ProMetic Life (TSX: PLI), the Healthcare company, has received a rating update from a Wall Street analyst today. Analyst Dewey Steadman from Canaccord Genuity rated ProMetic Life (TSX: PLI) a Buy, setting a C$2 price target. Steadman commented: “We think